Log-in
Sign-up
Webcast
Clinical Trials
Library
Webcast
Clinical Trials
Library
Home
>
Clinical Trials
Molecules
전체
Edoxaban
Olmesartan
Prasugrel
Pravastatin
Mirogabalin
Ramosetron
Trastuzumab deruxtecan
Status
Select
Check All
Search
Recruiting
Completed
Not yet recruiting
Enrolling by invitation
Active, not recruiting
Suspended
Terminated
Withdrawn
Unknown status
Email
Saved trials
RECRUITING
NCT05704829
NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer
702
Enrollment(s)
44
Study location(s)
INTERVENTIONAL (PHASE2)
HER2-positive Early Breast Cancer
ACTIVE_NOT_RECRUITING
NCT05113251
Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer
927
Enrollment(s)
145
Study location(s)
INTERVENTIONAL (PHASE3)
Breast Neoplasms
Breast Cancer
HER2-positive Early Breast Cancer
COMPLETED
NCT05035277
AntiCoagulation Versus AcetylSalicylic Acid After Transcatheter Aortic Valve Implantation
360
Enrollment(s)
3
Study location(s)
INTERVENTIONAL (PHASE3)
Aortic Stenosis
TERMINATED
NCT04100135
GORE® CARDIOFORM Septal Occluder Migraine Clinical Study
7
Enrollment(s)
15
Study location(s)
INTERVENTIONAL (NA)
Migraine
Patent Foramen Ovale
PFO - Patent Foramen Ovale
NOT_YET_RECRUITING
NCT07630103
Efficacy and Safety of Trastuzumab Rezetecan or Trastuzumab Deruxtecan in Advanced Breast Cancer
100
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE2)
Advanced Breast Cancer
RECRUITING
NCT07086768
Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors
57
Enrollment(s)
1
Study location(s)
INTERVENTIONAL (PHASE1)
Solid Tumor
Advanced Solid Tumor
Metastatic Solid Tumor
RECRUITING
NCT06486883
Safety and Efficacy of T-DXd vs. CDK4/6i-based ET as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype
200
Enrollment(s)
72
Study location(s)
INTERVENTIONAL (PHASE2)
Advanced Breast Cancer
Advanced Breast Carcinoma
Hormone Receptor Positive Breast Carcinoma
COMPLETED
NCT04981041
Escalated Single Platelet Inhibition for One Month Plus NOAC in Patients With Atrial Fibrillation and ACS Undergoing PCI
602
Enrollment(s)
37
Study location(s)
INTERVENTIONAL (PHASE4)
Acute Coronary Syndrome
Atrial Fibrillation
6
7
8
9
10